Целесообразность эмпирической антибактериальной терапии при инфекционном уретрите у мужчин: экспертное мнение дерматовенеролога и медицинского юриста

1. Young A., Toncar A., Wray AA. Urethritis. StatPearls. StatPearls Publishing, 2023, StatPearls Publishing LLC.

2. Sadoghi B., Kränke B., Komericki P, Hutterer G. Sexually transmitted pathogens causing urethritis: A mini-review and proposal of a clinically based diagnostic and therapeutic algorithm. Front Med (Lausanne). 2022;9:931765. https://doi.org/10.3389/fmed.2022.931765

3. Calas A., Zemali N., Camuset G., et al. Prevalence of urogenital, anal, and pharyngeal infections with Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium: a crosssectional study in Reunion island. BMC Infect Dis. 2021;21(1):95. https://doi.org/10.1186/s12879-021-05801-9

4. Cutoiu A., Boda D. Prevalence of Ureaplasma urealyticum, Mycoplasma hominis and Chlamydia trachomatis in symptomatic and asymptomatic patients. Biomed Rep. 2023;19(4):74. https://doi.org/10.3892/br.2023.1656

5. Ratnappuli A., Bissessor M., Arumugam S., et al. Culture obtained from urethral swab of asymptomatic men who screen positive for Neisseria gonorrhoeae by urine nucleic acid amplification testing. Sex Transm Infect. 2022;98(2):139–141. https://doi.org/10.1136/sextrans-2020-054690

6. Jansen K., Steffen G., Potthoff A,. et al.; MSM Screening Study group. STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany. BMC Infect Dis. 2020;20(1):110. https://doi.org/10.1186/s12879-020-4831-4

7. Красносельских Т.В., Соколовский Е.В., Рахматулина М.Р. и др. Заболеваемость сифилисом и некоторыми другими ИППП в Российской Федерации: прошлое, настоящее и пути достижения контроля эпидемиологической ситуации в будущем. Вестник дерматологии и венерологии. 2023;99(4):41–59. [Krasnoselskikh T.V., Sokolovskiy E.V., Rakhmatulina M.R., et al. Syphilis and some other STIs in the Russian Federation: past, present and ways to control of the epidemiological situation in the future. Vestnik dermatologii i venerologii. 2023;(99)4:41–59. (In Russ.)]. https://doi.org/10.25208/vdv13726

8. Björnelius E., Lidbrink P., Jensen J.S. Mycoplasma genitalium in non-gonococcal urethritis a study in Swedish male STD patients. Int J STD AIDS. 2000;11(5):292–6. https://doi.org/10.1177/095646240001100504

9. Donati M., Di Francesco A., D’Antuono A., et al. Chlamydia trachomatis serovar distribution and other concurrent sexually transmitted infections in heterosexual men with urethritis in Italy. Eur J Clin Microbiol Infect Dis. 2009;28(5):523–6. https://doi.org/10.1007/s10096-008-0650-z

10. Rossignol L., Feuillepain L., Ndeikoundam Ngangro N., et al. Estimate of male urethritis incidences in France between 2007 and 2017 with a specific focus on Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis infections. BMC Infect Dis. 2019;19:561. https://doi.org/10.1186/s12879-019-4202-1

11. Rowley J., Vander Hoorn S., Korenromp E., et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97(8):548–562P. https://doi.org/10.2471/BLT.18.228486

12. Zheng Y., Yu Q., Lin Y., et al. Global burden and trends of sexually transmitted infections from 1990 to 2019: an observational trend study. Lancet Infect Dis. 2022;22(4):541–551. https://doi.org/10.1016/s1473-3099(21)00448-5

13. Getman D., Jiang A., O’Donnell M., Cohen S. Mycoplasma genitalium Prevalence, Coinfection, and Macrolide Antibiotic Resistance Frequency in a Multicenter Clinical Study Cohort in the United States. J Clin Microbiol. 2016;54(9):2278–2283. https://doi.org/10.1128/Jcm.01053-16

14. Hart T., Tang W.Y., Mansoor S.A.B., et al. Mycoplasma genitalium in Singapore is associated with Chlamydia trachomatis infection and displays high macrolide and Fluoroquinolone resistance rates. BMC Infect Dis. 2020;20(1):314. https://doi.org/10.1186/s12879-020-05019-1

15. Хрянин А.А. Устойчивость к противомикробным препаратам при инфекциях, передаваемых половым путем: современные тенденции. Антибиотики и Химиотерапия. 2023;68(9-10):93–101. [Khryanin A.A. Antimicrobial Resistance in Sexually Transmitted Infections: Current Trends. Antibiotics and Chemotherapy. 2023;68(9-10):93–101. (In Russ.)]. https://doi.org/10.37489/0235-2990-2023-68-9-10-93-101

16. Vives A., Cosentino M., Bassas L., et al. Epidemiological, clinical and laboratory differences between male urethral infections due to Haemophilus spp. and those due to Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium and Ureaplasma urealyticum: A descriptive study. Arch Ital Urol Androl. 2021;93(4):468–474. https://doi.org/10.4081/aiua.2021.4.468

17. Bellinato F., Maurelli M., Gisondi P., et al. Clinical profile and coinfections of urethritis in males. Ital J Dermatol Venerol. 2021;156(6):681–685. https://doi.org/10.23736/S2784-8671.20.06773-5

18. Manhart L.E., Gillespie C.W., Lowens M.S., et al. Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clin Infect Dis. 2013;56(7):934–42. https://doi.org/10.1093/cid/cis1022

19. Jordan S.J., Toh E., Williams J.A., et al. Aetiology and prevalence of mixed-infections and monoinfections in non-gonococcal urethritis in men: a case-control study. Sex Transm Infect. 2020;96(4):306–311. https://doi.org/10.1136/sextrans-2019-054121

20. Wetmore C.M., Manhart L.E., Golden M.R. Idiopathic urethritis in young men in the United States: prevalence and comparison to infections with known sexually transmitted pathogens. J Adolesc Health. 2009;45(5):463–72. https://doi.org/10.1016/j.jadohealth.2009.06.024

21. Srinivasan S., Chambers L.C., Tapia K.A., et al. Urethral Microbiota in Men: Association of Haemophilus influenzae and Mycoplasma penetrans With Nongonococcal Urethritis. Clin Infect Dis. 2021;73(7):e1684-e1693. https://doi.org/10.1093/cid/ciaa1123.

22. Plummer E.L., Ratten L.K., Vodstrcil L.A., et al. The Urethral Microbiota of Men with and without Idiopathic Urethritis. mBio. 2022;13(5):e0221322. https://doi.org/10.1128/mbio.02213-22

23. Frølund M., Wikström A., Lidbrink P., et al. The bacterial microbiota in first-void urine from men with and without idiopathic urethritis. PLoS One. 2018;13(7):e0201380. https://doi.org/10.1371/journal.pone.0201380

24. Manhart L.E., Khosropour C.M., Liu C., et al. Bacterial vaginosis-associated bacteria in men: association of Leptotrichia/Sneathia spp. with nongonococcal urethritis. Sex Transm Dis. 2013;40(12):944–9. https://doi.org/10.1097/olq.0000000000000054

25. Rietmeijer C.A., Mettenbrink C.J. Recalibrating the Gram stain diagnosis of male urethritis in the era of nucleic acid amplification testing. Sex Transm Dis. 2012;39(1):18–20. https://doi.org/10.1097/OLQ.0b013e3182354da3

26. Horner P.J., Blee K., Falk L., et al. 2016 European guideline on the management of non-gonococcal urethritis. Int J STD AIDS. 2016;27(11):928-37. https://doi.org/10.1177/0956462416648585

27. Cole M.J., Quinten C., Day M., et al.; Euro-GASP network. The European gonococcal antimicrobial surveillance programme, 2009–2016: findings and implications. Sex Transm Infect. 2019;95(7):488–499. https://doi.org/10.1136/sextrans-2018-053803

28. Soni S., Horner P.J. Update on the management of nongonococcal urethritis. Curr Opin Infect Dis. 2019;32(1):44–49. https://doi.org/10.1097/QCO.0000000000000516.

29. Kissinger P., White S., Manhart L.E. Management of Mycoplasma genitalium infection in the USA: expert consensus guidelines. Lancet Infect Dis. 2022;22(9):e222–e227. https://doi.org/10.1016/S1473-3099(22)00151-1

30. Workowski K.A., Bachmann L.H., Chan P.A., et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1–187. https://doi.org/10.15585/mmwr.rr7004a1

31. Horner P., Blee K., O’Mahony C., et al.; Clinical Effectiveness Group of the British Association for Sexual Health and HIV. 2015 UK National Guideline on the management of nongonococcal urethritis. Int J STD AIDS. 2016;27(2):85–96. https://doi.org/ 10.1177/0956462415586675

32. Fifer H., Saunders J., Soni S., et al. 2018 UK national guideline for the management of infection with Neisseria gonorrhoeae. Int J STD AIDS. 2020;31(1):4–15. https://doi.org/10.1177/0956462419886775

33. Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR Recomm Rep. 2008;57(Rr-9):1–83; quiz CE1-4.

34. John S.A., Starks T.J., Rendina H.J., et al. High willingness to use novel HIV and bacterial sexually transmitted infection partner notification, testing, and treatment strategies among gay and bisexual men. Sex Transm Infect. 2020;96(3):173–176. https://doi.org/10.1136/sextrans-2019-053974

35. Приказ Минздрава России от 13.01.2026 № 15н «Об утверждении стандарта первичной медико-санитарной помощи взрослым при негонококковом (неспецифическом) уретрите у мужчин (диагностика и лечение)». [Order of the Ministry of Health of the Russian Federation dated January 13, 2026, No. 15n, «On Approval of the Standard of Primary Health Care for Adults with Non-Gonococcal (Nonspecific) Urethritis in Men (Diagnosis and Treatment)». (In Russ.)].

36. Портнягина Е.В., Раднаев Г.Г. Рациональная антибактериальная терапия и вопросы предупреждения бактериальной резистентности: учеб. пособие. Иркутск: ИГМУ, 2022. 135 с. [Portnyagina E.V., Radnaev,G.G. Rational Antibacterial Therapy and Prevention of Bacterial Resistance: A Textbook. Irkutsk: Irkutsk State Medical University, 2022. 135 p. (In Russ.)].

37. Клинические рекомендации «Гонококковая инфекция». URL: https://minzdrav.gov.ru (дата доступа: 09.07.2024). В соответствии с Постановлением Правительства РФ от 17.11.2021 № 1968 данный документ применяется с 1 января 2025 г. Текст документа приведен в соответствии с публикацией на сайте по состоянию на 31.07.2025. [Clinical Guidelines «Gonococcal Infection.» Official website of the Ministry of Health of the Russian Federation: https://minzdrav.gov.ru (accessed July 9, 2024). In accordance with RF Government Resolution No. 1968 dated November 17, 2021, this document shall apply from January 1, 2025. The text of the document is presented in accordance with the publication on the website as of July 31, 2025. (In Russ.)].

38. Клинические рекомендации «Негонококковый (неспецифический) уретрит у мужчин». URL: https://minzdrav.gov.ru/, 07.10.2024 (дата доступа 07.04.2026). В соответствии с Постановлением Правительства РФ от 17.11.2021 N 1968 данный документ применяется с 1 января 2025 г. Текст документа приведен в соответствии с публикацией на сайте по состоянию на 31.07.2025. [Clinical guidelines «Non-gonococcal (nonspecific) urethritis in men.» URL: https://minzdrav.gov.ru/, October 7, 2024 (accessed April 7, 2026). In accordance with RF Government Resolution No. 1968 of November 17, 2021, this document shall apply from January 1, 2025. The text of the document is presented in accordance with the publication on the website as of July 31, 2025. (In Russ.)].

39. Официальный сайт Росстата. [Official website of Rosstat. (In Russ.)]. URL: http://government.ru/docs/

40. Кодекс Российской Федерации об административных правонарушениях от 30.12.2001 № 195-ФЗ (ред. от 09.04.2026, с изм. от 29.04.2026). URL: http://pravo.gov.ru (дата доступа: 09.04.2026). [Code of the Russian Federation on Administrative Offenses of December 30, 2001, No. 195-FZ (as amended on April 9, 2026, as amended on April 29, 2026). URL: http://pravo.gov.ru (accessed: April 9, 2026). (In Russ.)].

41. Lorenzo-Pinto A., Ortego-Navarro C., Torroba-Sanz B., et al. Appropriateness of Empirical Antibiotic Therapy for Cervicitis and Urethritis Prescribed in the Emergency Department. Hosp Pharm.2023;58(1):106-110. doi: 10.1177/00185787221123219

42. Клинический фармаколог предупредил врачей о рисках из-за назначения препаратов офф-лейбл. Статья от 06.03.2026. [A clinical pharmacologist warned doctors about the risks of prescribing off-label drugs. Article dated March 6, 2026. (In Russ.)]. URL: https://medvestnik.ru/content/news/klinicheskii-farmakolog-predupredil-vrachei-o-riskah-iz-za-naznacheniya-preparatov-off-leibl.html (дата доступа/access date: 17.05.2026).

43. Распоряжение Правительства РФ от 18.12.2025 № 3867-р «Об утверждении перечня жизненно необходимых и важнейших лекарственных препаратов, а также перечней лекарственных препаратов для медицинского применения и минимального ассортимента лекарственных препаратов, необходимых для оказания медицинской помощи». URL: http://pravo.gov.ru, 24.12.2025 [Russian Government Order No. 3867-r dated December 18, 2025, «On approval of the list of vital and essential drugs, as well as lists of drugs for medical use and the minimum range of drugs required to provide medical care.» URL: http://pravo.gov.ru, December 24, 2025 (In Russ.)].

44. Инструкция по медицинскому применению препарата Джозафен. [Instructions for medical use of Josafen. (In Russ.)]. URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=da750ddf-f335-4a97-8bd5-8c2b98d83ca2